Cel Sci Corporation (CVM)

[Biobonic]

Amethyst Radiology Group in Europe

Amethyst Radiology Group

We operate 11 centres across Austria, France,
Italy, Poland, Romania and more recently UK.

High-tech radiotherapy is at the core of all
Amethyst Radiotherapy clinics and we strive
to offer oncological patients access
to the best treatments available.

CS001P3: Multi-centre Study of the Effects of Leukocyte Interleukin– COMPLETED*
Phase III, Open-label, Randomized, Multi-centre Study of the Effects of Leukocyte Interleukin, Injection (Multikine) plus Standard of Care (Surgery+ Radiotherapy or Surgery + Concurrent Chemoradiotherapy) in Subject with Advance Primary Squamous Cell Carcinoma of Oral Cavity / Soft Palate versus Standard of Care Only CEL-SCI Corporation, Protocol number: CS001P3.

As the provider of Radiation, it would make sense that their portion of the clinical trial is complete.
Don't think it speaks to the trial overall.